Clinical Trial Update: Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI) [Phase 1]

View source ↗

Summary

Phase 1 safety update on intramuscular injections of allogeneic PLX-PAD cells for the treatment of critical limb ischemia, with the trial status reported as com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• PLX PAD

Snippet

Sponsor: Pluristem Ltd. | Conditions: Peripheral Artery Disease, Peripheral Vascular Disease | Phase 1 | Status: COMPLETED